| __timestamp | Amphastar Pharmaceuticals, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 33534999 |
| Thursday, January 1, 2015 | 174172000 | 1982000 |
| Friday, January 1, 2016 | 150976000 | 2438000 |
| Sunday, January 1, 2017 | 149380000 | 2901000 |
| Monday, January 1, 2018 | 187681000 | 2423000 |
| Tuesday, January 1, 2019 | 190434000 | 24212000 |
| Wednesday, January 1, 2020 | 206506000 | 39872000 |
| Friday, January 1, 2021 | 238029000 | 44152000 |
| Saturday, January 1, 2022 | 250127000 | 55126000 |
| Sunday, January 1, 2023 | 293274000 | 65573000 |
Infusing magic into the data realm
Over the past decade, Amphastar Pharmaceuticals, Inc. and Insmed Incorporated have shown distinct trajectories in their cost of revenue. Amphastar's cost of revenue has surged by approximately 84% from 2014 to 2023, reflecting its expanding operations and market presence. In contrast, Insmed's cost of revenue, while significantly lower, has increased by an impressive 95% over the same period, indicating its strategic growth initiatives.
In 2023, Amphastar's cost of revenue reached its peak, nearly doubling since 2014, showcasing its robust market strategy. Meanwhile, Insmed's cost of revenue, though starting from a smaller base, has shown a consistent upward trend, highlighting its commitment to scaling operations. These insights provide a window into the financial strategies and market dynamics of these two pharmaceutical giants, offering valuable lessons for investors and industry analysts alike.
Cost of Revenue Comparison: Amgen Inc. vs Insmed Incorporated
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Amphastar Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: United Therapeutics Corporation vs Insmed Incorporated
Cost Insights: Breaking Down Viatris Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Insmed Incorporated vs Pharming Group N.V.
Cost of Revenue Comparison: Insmed Incorporated vs Veracyte, Inc.
Dr. Reddy's Laboratories Limited vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Catalent, Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Amneal Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue Comparison: Perrigo Company plc vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and MiMedx Group, Inc.